Pharma · Private company
CSL Behring
Track this companyFree. Adds CSL Behring to your Dealase workspace and tells you when its record changes.
Clinical trials2514 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- AATPhase 3 · Acute-graft-versus-host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AAV5-hFIXco-PaduaPhase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- Alpha-1 antitrypsin (AAT)Phase 3 · Graft Versus Host Disease (GVHD)ClinicalTrials.gov · fetched Nov 12, 2026
- BE1116Phase 3 · Traumatic InjuryClinicalTrials.gov · fetched Nov 12, 2026
- BE1116Phase 3 · Complex Cardiovascular Surgery With Cardiopulmonary BypassClinicalTrials.gov · fetched Nov 12, 2026
- CSL222 (AAV5-hFIXco-Padua)Phase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua)Phase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- CSL300Phase 3 · End Stage Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CSL312Phase 3 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- CSL312Phase 3 · Hereditary Angioedema (HAE)ClinicalTrials.gov · fetched Nov 12, 2026
- Factor IX (FIX)Phase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- FFPPhase 3 · Complex Cardiovascular Surgery With Cardiopulmonary BypassClinicalTrials.gov · fetched Nov 12, 2026
- IgPro20Phase 3 · Secondary Immune DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- IgPro20Phase 3 · Post-COVID Postural Orthostatic Tachycardia SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- AnumigilimabPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CSL889Phase 2 · Sickle Cell Disease Vaso-occlusive CrisisClinicalTrials.gov · fetched Nov 12, 2026
- VamifeportPhase 2 · Homeostatic Iron Regulator Gene-related Hereditary HemochromatosisClinicalTrials.gov · fetched Nov 12, 2026
- GaradacimabHereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- HEMGENIXHemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- IgProPrimary ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- IgPro10Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)ClinicalTrials.gov · fetched Nov 12, 2026
- No interventionHereditary AngioedemasClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesPHASE3 · RECRUITING · started Sep 15, 2026ClinicalTrials.gov NCT07648264 · fetched Nov 12, 2026
- Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)PHASE2 · RECRUITING · started Feb 2, 2026ClinicalTrials.gov NCT07224360 · fetched Nov 12, 2026
- Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 22, 2026ClinicalTrials.gov NCT07332091 · fetched Nov 12, 2026
- Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)PHASE3 · RECRUITING · started Sep 15, 2025ClinicalTrials.gov NCT07094087 · fetched Nov 12, 2026
- Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia BPHASE3 · RECRUITING · started Jul 28, 2025ClinicalTrials.gov NCT07080905 · fetched Nov 12, 2026
- A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)RECRUITING · started Jul 21, 2025ClinicalTrials.gov NCT07001280 · fetched Nov 12, 2026
- An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)PHASE4 · COMPLETED · started Jul 15, 2025ClinicalTrials.gov NCT07076446 · fetched Nov 12, 2026
- Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive CrisisPHASE2 · RECRUITING · started Jul 10, 2025ClinicalTrials.gov NCT06699849 · fetched Nov 12, 2026
- Zemaira Eosinophilic Esophagitis Pilot StudyPHASE2 · RECRUITING · started May 15, 2025ClinicalTrials.gov NCT05485155 · fetched Nov 12, 2026
- Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to GaradacimabPHASE4 · COMPLETED · started Apr 28, 2025ClinicalTrials.gov NCT06806657 · fetched Nov 12, 2026
- Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTSPHASE3 · TERMINATED · started Aug 28, 2024ClinicalTrials.gov NCT06524739 · fetched Nov 12, 2026
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)PHASE2_PHASE3 · RECRUITING · started Apr 27, 2024ClinicalTrials.gov NCT05485961 · fetched Nov 12, 2026
- Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)PHASE3 · RECRUITING · started Jan 30, 2024ClinicalTrials.gov NCT06003387 · fetched Nov 12, 2026
- Usage of Spirometry in Managing IgG Therapy in CVID With Airway DiseasePHASE4 · RECRUITING · started Jan 15, 2024ClinicalTrials.gov NCT05193552 · fetched Nov 12, 2026
- Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)ENROLLING_BY_INVITATION · started Aug 30, 2023ClinicalTrials.gov NCT05962398 · fetched Nov 12, 2026
- Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT StudyPHASE2 · COMPLETED · started Aug 1, 2023ClinicalTrials.gov NCT05727384 · fetched Nov 12, 2026
- An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia BRECRUITING · started Jun 15, 2023ClinicalTrials.gov NCT06008938 · fetched Nov 12, 2026
- CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary AngioedemaPHASE3 · COMPLETED · started May 30, 2023ClinicalTrials.gov NCT05819775 · fetched Nov 12, 2026
- Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )PHASE3 · TERMINATED · started Mar 28, 2023ClinicalTrials.gov NCT05568888 · fetched Nov 12, 2026
- Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema AttacksPHASE3 · COMPLETED · started Mar 29, 2021ClinicalTrials.gov NCT04739059 · fetched Nov 12, 2026
- Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids AlonePHASE3 · COMPLETED · started Jan 9, 2020ClinicalTrials.gov NCT04167514 · fetched Nov 12, 2026
- The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell TransplantPHASE2_PHASE3 · TERMINATED · started Mar 27, 2019ClinicalTrials.gov NCT03805789 · fetched Nov 12, 2026
- Two Dose Levels of Privigen in Pediatric CIDPPHASE4 · RECRUITING · started Feb 28, 2019ClinicalTrials.gov NCT03684018 · fetched Nov 12, 2026
- Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart TransplantationPHASE3 · TERMINATED · started Jul 11, 2018ClinicalTrials.gov NCT03341156 · fetched Nov 12, 2026
- HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B PatientsPHASE3 · COMPLETED · started Jun 27, 2018ClinicalTrials.gov NCT03569891 · fetched Nov 12, 2026